MedTrace Logo

The Validity and Reliability of an Improved Paper Grasping Test for Parkinson's Disease

NCT07772622 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-08-19

No results posted yet for this study

Summary

The study will include volunteer patients diagnosed with Parkinson's disease who applied to the Neurology Outpatient Clinic at SANKO University Sani Konukoğlu Application and Research Hospital.

Patients who meet the inclusion criteria will be evaluated by Dr. Hakan Polat and Physiotherapist Fatma Yılmaz in the application laboratory of the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, SANKO University.

The assessment form prepared by the researchers will be completed face-to-face with the patients. First, demographic information and disease-related data (duration since Parkinson's diagnosis, disease stage, affected side, etc.) will be recorded. The Mini-BESTest will be used to evaluate balance and gait. The muscle strength of the ankle plantar flexor and dorsiflexor muscles will be assessed using a manual muscle testing device, and quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39).

Since fall problems in patients may be related to balance impairments, lower limb muscle weakness, and reduced quality of life, these parameters will also be evaluated. Therefore, in this study, while examining the validity and reliability of the modified paper grip test in individuals with Parkinson's disease, its correlation with these parameters will also be investigated.

Before administering the tests, participants will receive a practical explanation of how the tests are performed and will be allowed to rest prior to assessment. The tests will be administered in the following order: first, the paper grip test by Dr. Hakan Polat, followed by the Mini-BESTest, assessment of ankle plantar and dorsiflexor muscle strength, and evaluation of quality of life.

One week after the initial assessment, only the paper grip test will be re-administered by Physiotherapist Fatma Yılmaz in the same environment. This approach will minimize the effect of environmental factors on the patients' performance.

Conditions

Sponsors & Collaborators

  • Sanko University

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-10
Primary Completion
2026-01-12
Completion
2026-06-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07772622 on ClinicalTrials.gov